Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2009 by Tongji University
Sponsor:
Collaborator:
Interventional Radiology Research Group, Shanghai Radiology Society
Information provided by:
Tongji University
ClinicalTrials.gov Identifier:
NCT00960518
First received: August 14, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)